Jagged-2, a signaling protein, may be a potential therapeutic target for slowing or halting the progression of PAH, according ...

Two Phase 3 clinical trials testing the experimental therapy TNX-103 in people with PH-HFpEF are currently recruiting ...

Uptravi may reduce blood pressure in the lungs of children with pulmonary arterial hypertension, according to a meta-analysis ...

Columnist Jen Cueva thought she had the flu, but it turned out to be much more serious. She says that with PH, life often gives you lemons.

During the holidays, I love spending time in the kitchen, using all my favorite devices to bake cookies and other treats that remind me of past Christmas celebrations. With a stand mixer, food ...

A committee of the European Medicines Agency (EMA) has recommended expanding the indication for Winrevair (sotatercept-csrk), Merck’s approved injection therapy for adults with pulmonary arterial ...

A week or two before I had a heart and lung transplant seven years ago, my mom and I had lunch with a friend who was a pulmonary hypertension survivor and had received a transplant two years earlier.

Altered activity of a protein called PUM1 plays a key role in the development of pulmonary hypertension (PH), according to a new study done in animal and cell models. “Our study establishes PUM1 as a ...

Tiakis Biotech is set to advance its experimental therapy tiprelestat into a Phase 2 clinical trial for pulmonary arterial hypertension (PAH), after successfully finalizing the data package required ...

When you live with a chronic and complex illness, complications and side effects from the medications to treat it are always lurking around the corner — even in the most stable of times. The more ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...